Skip to content
The U.S. Food and Drug Administration (FDA) approved last week Sanofi Genzyme’s Xenpozyme “for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase […]
FDA approves Sanofi’s Xenpozyme, the first treatment for ASMD Read More »
Preventable risk factors, including smoking and drinking alcohol, are the main cause of approximately 50% of cancer deaths, says a new study. A large-scale
Preventable risk factors cause 50% of cancer deaths globally Read More »
It’s an exciting time for research into microbiome therapeutics. This can be seen in the explosion of new clinical studies in the field, which,
A gut check on microbiome therapeutics development Read More »
